Global heart organizations issued a joint statement calling for action on environmental stressors including air pollution.

Systemic inflammation has been elevated to a modifiable cardiovascular risk factor requiring assessment, monitoring, and modification, based on consensus recommendations.

Please provide your email address to receive an email when new articles are posted on . A 0.5 mg dose of colchicine, a drug commonly used for conditions such as gout, was recently approved by the FDA ...

Analysis of the FOURIER trial shows that evolocumab provides greater MACE risk reduction in patients with higher BMI and stable ASCVD.

Please provide your email address to receive an email when new articles are posted on . Researchers found that patients with a positive SARS-CoV-2 PCR test faced an increased risk for major adverse ...

This month: cuffless BP issues in practice, women and lifetime CVD risk, targeting kids for early education, and more.

The risk for CV events was increased among patients who were hospitalized for COVID-19, though it was heightened by preexisting CV conditions and mitigated by vaccination.

Wegovy tablets offer a daily oral alternative to injections for weight reduction and reducing cardiovascular risk in eligible adult patients.

This episode features Marc Sakwa, MD, Chief of CT Surgery, MemorialCare, Chief, CV Surgery, MemorialCare Heart & Vascular Institute; Medical Director, Adult CV Surgery, MHVI at Long Beach Medical ...

Adults aged 60 or older who took high monthly doses of vitamin D for 5 years failed to show a significant drop in risk for cardiovascular (CV) events in general but may have benefited for other CV ...